HIV/TB Co-infection

Tens of thousands of people living with HIV and tuberculosis  in Myanmar are unable to access lifesaving antiretroviral therapy, a dire situation exacerbated by the recent cancellation of a new round of funding from the Global Fund to Fight AIDS, TB, and Malaria.

A new MSF report warns that cancellation of global fund grants will have devastating effect in Myanmar.

While international attention focuses on Myanmar, a health crisis in the country looms large. An estimated 85,000 people infected with HIV in Myanmar are not receiving lifesaving treatment. 

MSF responds to the unprecedented decision taken to cancel a funding round of the Global Fund to Fight AIDS, TB and Malaria.

An MSF outreach counselor in southern Myanmar travels village to village as part of the effort to treat HIV/AIDS and HIV-TB co-infection in the country.

Despite some encouraging trends among people living with HIV in Mozambique, a great deal of work remains to be done.

The dual epidemic of tuberculosis and HIV is devastating Swaziland, cutting life expectancy there from 60 to just 31 years of age, MSF said today in a new report.

After ten years of providing integrated healthcare for people living with HIV/AIDS in Busia, MSF is ready to hand over the program.

Lay counselors are an intergral part of MSF's TB and HIV programs in Lesotho, and each has a story to tell.

The beautiful, mountainous landscape is visible through the windows, but the patients here are all in serious condition, suffering from tuberculosis (TB), the leading cause of death of people living with HIV in Lesotho.

At one time, TB was considered on its way to being eradicated. However, the disease started a frightening comeback beginning in the 1980s and lasting through the present day.

The World Health Organization estimates that one million children each year develop TB, the vast majority of whom live in resource-poor settings.

No doubt strides have been made in giving more people access to anti-retroviral drugs. But will the progress continue? Jim Clancy put that question to Emi Maclean, Director of the Doctors Without Borders Access Campaign.

Participants at an International Consultative Workshop that took place at the end of October in Swaziland have come up with a series of recommendations to improve and increase the response to the alarming dual epidemic of HIV/AIDS and tuberculosis (TB) that is claiming thousands of lives every year in the Southern African region and in Swaziland in particular.

“I understand what other patients are going through because, after all, I am also a patient. I take a minimum of 15 pills each day just to fight against drug-resistant TB."

MSF doctor Hermann Reuter works in a tuberculosis (TB) project in a rural district of Swaziland called Shiselweni.

Swaziland in Southern Africa is on the brink of a major health crisis due to the killer twin epidemic of HIV-AIDS and TB.

Alison Wong was the pharmacist for the Doctors Without Borders/Médecins Sans Frontières (MSF) HIV/AIDS program at Arua Regional Referral Hospital in Uganda from September 2005 to October 2006. MSF began the program in 2001 to provide antiretroviral (ARV) treatment to people in the region living with HIV. It has grown to include treatment for people co-infected with HIV and TB, and to establishing better decentralized care.